Pursuant to SEBI Circular - SEBI/ HO/ DDHS/CIR/ P/ 2018/ 144 dated November 26, 2018, Welcure Drugs & Pharmaceuticals has informed that it enclosed Annual Disclosure for the Financial Year 2021-22 as ‘Annexure B2’. It is informed that there was no incremental borrowing applicable to the company during the financial year 2021-22 as per explanation provided in the aforesaid circular; therefore, the said circular is not applicable on the company.
The above information is a part of company’s filings submitted to BSE.